Fourth vaccine dose boosts antibodies, researchers say, but likely not enough to prevent Omicron breakthrough infections

Early data out of Israel suggests that a fourth dose of either the Pfizer/BioNTech or Moderna coronavirus vaccine can bring an increase in antibodies -- more than what's been seen after a third dose -- but it still might not be enough to protect against breakthrough infections caused by the Omicron variant.

Click Here to read the entire article...